Metraipolis › archive › dc_8e905b7c2aaa

Comparison of Standard of Care with or Without a PD-1/PD-L-1 Inhibitor for the Treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase… — Europe PMC PMID:41374932

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41374932
DOI
10.3390/cancers17233730
License (as archived)
solo-consultazione
Archived
2026-11-08T08:41:01.393Z
SHA-256 of the archived text
efbf885bd611fc648d4779f9552d2c84a2ff15671ded80cca8c69ecd6bcb4d37
Stable URL of this page
https://metraipolis.com/documento/dc_8e905b7c2aaa

How to cite

Comparison of Standard of Care with or Without a PD-1/PD-L-1 Inhibitor for the Treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase… — Europe PMC PMID:41374932 — Europe PMC (en), https://europepmc.org/article/MED/41374932 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8e905b7c2aaa (Metraipolis archive dc_8e905b7c2aaa, sha256 efbf885bd611fc648d4779f9552d2c84a2ff15671ded80cca8c69ecd6bcb4d37)
BibTeX
@misc{dc8e905b7c2aaa,
  title = {Comparison of Standard of Care with or Without a PD-1/PD-L-1 Inhibitor for the Treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase… — Europe PMC PMID:41374932},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41374932},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8e905b7c2aaa; sha256 efbf885bd611fc648d4779f9552d2c84a2ff15671ded80cca8c69ecd6bcb4d37},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41374932. Agents can read the archived copy with the MCP tool read_document.